Cited by 1,018Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationArtificial Intelligence Applications

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Artificial intelligence in drug development: present status and future prospects

Mak, Kit-Kay, Pichika, Mallikarjuna Rao·2019·Drug Discovery Today

DOI 10.1016/j.drudis.2018.11.014

Open this paper in CoChat — free account

Abstract

Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process. At present, the pharmaceutical industry is facing challenges in sustaining their drug development programmes because of increased R&D costs and reduced efficiency. In this review, we discuss the major causes of attrition rates in new drug approvals, the possible ways that AI can improve the efficiency of the drug development process and collaboration of pharmaceutical industry giants with AI-powered drug discovery firms.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2018.11.014

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Artificial intelligence in healthcare: past, present and future
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep Learning in Medical Imaging: General Overview
Lee, J., Jun, S., Cho, Y.-W., Lee, H., Kim, G. B., Seo, J. B., & Kim, N. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.4.570 · Cited by 1,328
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185

Show all 73 references

Sorted by citations

Items 801–900 of 1,000

Semantic Review of Artificial Intelligence Architectures in Drug Discovery
Ananya, Arora, E., Mohil, V., & Sharma, A. (2024) · Lecture notes in electrical engineering · doi:10.1007/978-981-99-7383-5_24
A New Era of Healthcare: The Convergence of Artificial Intelligence and Pharmaceuticals
Vinchurkar, K. (2024) · Pharmaceutical Drug Regulatory Affairs Journal · doi:10.23880/pdraj-16000149
Intelligent Hardware-Software Processing of High-Frequency Scanning Data
Mukanova, Z., Atanov, S. K., & Jamshidi, M. (2023) · Journal of Robotics and Control (JRC) · doi:10.18196/jrc.v4i5.18915
Virtual Tools and Screening Designs for Drug Discovery and New Drug Development
Dubey, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223019124010007
Computational pharmaceutics
Bayan, M. F., Chandrasekaran, B., Mansour, N., Alrefaie, Y., Ashour, K., & Pathan, H. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00010-2
Digital Technologies in Health Care: A Comprehensive Review of Current Status and Future Perspectives
Ghafar, Z. N. (2024) · International Journal of Applied and Scientific Research · doi:10.59890/ijasr.v2i3.1558 · Cited by 1
Data mining patterns of receptor-drug interactions across vast biological and chemical space
Witts, J. (2020) · doi:10.23889/suthesis.65941
Nagy nyelvi modellek gyógyszeripari alkalmazhatóságának lehetőségei
Péterfi, O. (2024) · Rendvédelem · doi:10.53793/rv.2024.1.6
Leveraging OpenAI for Enhanced Multifactor Productivity in Chinese Businesses
Zreık, M. (2024) · Advances in logistics, operations, and management science book series · doi:10.4018/979-8-3693-1198-1.ch004
A Study on the Data Science in the Age of Covid
Deo, J. S., & Jaiswal, S. (2023) · International Journal of Advance Research and Innovation · doi:10.51976/ijari.1112308
Role of Artificial Intelligence in Pharmacy
Satkar, M. S. S., Jadhav, M. P. A., & Randhe, M. T. A. (2024) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-18075
Potential Antibacterial Activity for the 3,4-Dihydropyrimidone Variants Against Mtcc-451 & Vp-S14: Invitro & Insilico Like 2d-Qsar, Molecular Docking, Dft and Adme/T StudiesPreprint
AMEEN, S. T. S., Paringamalai, N., Ibrahim, A. M., Ahmed, J., & Ramalingam, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4848789
Model‐informed Drug Development ( MIDD ) Regarding Regulatory Requirements and Thinking
Wang, W., Wang, Y., & Ouyang, D. (2024) · doi:10.1002/9781119987260.ch18
Harnessing Artificial Intelligence for the Design and Development of Novel Effective Medicines
Salman, M. S., Mohammed, F. A., & Haanooon, F. S. (2024) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2024.07.1390
Potential of AI in Pharma: Bridge the Gap Between Data and Therapeutics
Chitara, D., Verma, A., & Kumar, P. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-97-3604-1_20
New Health Technologies and Regulatory Approaches
Demetzos, C. (2024) · doi:10.1002/9781394274086.ch7
THE IMPACT OF ARTIFICIAL INTELLIGENCE ON DRUG DISCOVERY
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets60664
Integrating the AI-Driven Technologies Into Pharmaceutical Service Marketing
Singh, K., Singh, S., Wadhwa, S., & Baghel, D. S. (2024) · Advances in marketing, customer relationship management, and e-services book series · doi:10.4018/979-8-3693-7122-0.ch019
Mesocorticolimbic and Cardiometabolic Diseases—Two Faces of the Same Coin?
Papp, C., Mikáczó, A., Szabo, J., Móré, C. E., Viczján, G., Gesztelyi, R., & Zsuga, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179682
Artificial intelligence's impact on contemporary drug research and pharmaceutical formulation
Daniel, X. P. (2024) · i-manager s Journal on Chemical Sciences · doi:10.26634/jchem.4.1.21156
Artificial intelligence: A regulatory perspective
Branco, F., & Sousa, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91819-0.00002-6 · Cited by 1
How artificial intelligence affects the future of pharmacy practice?
Alajlan, S. A., & Lytras, M. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13619-1.00013-1
Regulatory Insights into Artificial Intelligence in Drug Delivery and Medical Devices
Sharma, N., Bisht, R., Sontakke, R., & Vinchurkar, K. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305753124010012
Artificial Intelligence in Community and Hospital Pharmacy
Yadav, S., Jain, P., Vinchurkar, K., & Mane, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305753124010007
Exploring the Fundamental Aspects of Artificial Intelligence: A Comprehensive Overview
Singh, A., Gulfisha, S., Koshta, A., & Mane, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305753124010005
Exploring Artificial Intelligence in Healthcare: A Precise Review
Baig, A. P., Janvalkar, M., Barse, R., & Jagtap, V. A. (2024) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0025 · Cited by 1
The role of artificial intelligence in advancing clinical biochemistry
Timalsina, D. R., Chavan, A., Hawale, D., & Thatere, A. B. (2024) · AIP conference proceedings · doi:10.1063/5.0240202
Applications of artificial intelligence in pharmaceutical manufacturing
Phutane, P., & Thakare, R. (2024) · AIP conference proceedings · doi:10.1063/5.0240390
Tuzlu Suda Metan Hidrat Oluşum Koşullarının Tahmini için Regresyon Algoritmalarının Karşılaştırmalı Analizi
Uzun, S. D., Onan, A., & Bulut, V. (2024) · Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.47495/okufbed.1116395
Sustainability in Drug Discovery Through Artificial Intelligence and Big Data
Özay, C., Kalem, R. N., Safarova, M., & Majidova, L. (2024) · Lecture notes in networks and systems · doi:10.1007/978-3-031-81564-5_40
Industrial Automation using Artificial Intelligence
Katkar, A., Karvande, P., & Sanap, G. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-22981
Quantitative Structure Interaction Activity Relationship (QSIAR) as a Novel Approach to Drug Design: A Case Study of Anti-tubercular Agents
Saxena, A. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-75457-9_1
AI-driven drug discovery and development
Khan, S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33584-6.00011-6
The Influence of Artificial Intelligence in Drug Discovery and Development
Krishnan, S., Rajendran, K., Yogeshwaran, V. N., & Radhakrishnan, B. (2024) · Medical virology · doi:10.1007/978-981-97-2938-8_3
Transformer-Based Novel Molecular Design Utilizing Scaffolds
Park, J., & Yoo, S. (2025) · Journal of Digital Contents Society · doi:10.9728/dcs.2025.26.1.217
A Review on Transforming Pharma :The Rise of Artificial Intelligence (AI)
Solat, G. D., Gore, R. B., Shirsat, G. A., Pawar, O., & Gholap, M. S. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-23274
Inappropriate polypharmacy during the COVID-19 pandemic: impact, challenges, and solutions – a narrative review
Gavazova, E., Staynova, R. A., & Grekova, D. (2025) · Folia Medica · doi:10.3897/folmed.67.e144169
Highly activated neddylation pathway in lung cancer and chemical targeted intervention
Qin, X., Yu, Q., Li, X., Xiong, X., Liu, P., Han, X., & Sun, Y. (2025) · Scientia Sinica Chimica · doi:10.1360/ssc-2025-0015
Artificial Intelligence in Predicting Hard Tissue Regeneration: Current Situation and Upcoming Perspectives
Brimo, N., Serdaroğlu, D. Ç., Muhittin, H., Kaplan, M., & Omira, A. (2025) · Tissue repair and reconstruction · doi:10.1007/978-981-96-1341-0_4 · Cited by 1
Exploring the Impact of Perceived Entrepreneurial Mindset and AI Adoption on Customer Experiences: A Study of Just Ask Chatbot Users
Hasan, S., & Simon, R. (2025) · Information systems engineering and management · doi:10.1007/978-3-031-84404-1_6
CHEMICAL INSIGHTS: QUANTUM TECHNOLOGY REDEFINES COMPUTATIONAL DRUG DEVELOPMENT
Arora, M., Tathed, R., Kulkarni, P. D., Ghante, M. R., & Sawant, V. N. (2025) · INDIAN DRUGS · doi:10.53879/id.62.03.15106
Artificial Intelligence in Pharmaceutical Drug Development-challenges and the Way Forward
Krishnaswami, V., Muruganantham, S., Raja, J., Arthanari, S., Selvaraj, B. R., & Dharmian, J. P. (2025) · Current Artificial Intelligence · doi:10.2174/0129503752359512250325061847
Aritifical Intelligence in Clinical Trials
Kalbhor, M. C. S. (2025) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2025.68764
Current and Emerging Uses of Generative AI for Clinical Care, Administration, and Research
Adirim, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-83526-1_6
Potential of Interactive VR and Digital Twin for Drug Development and Clinical Trials
Malviya, R., & Rajput, S. (2025) · Wiley eBooks · doi:10.1002/9781394315680.ch8
Drug Design and Discovery Through Artificial Intelligence
Shaikh, Z. P., & Bhise, S. B. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-6270-9.ch005
A Study on Consumer Perception Towards Purchasing Intentions of Online Pharmacy Products Using Generative Artificial Intelligence and Machine Learning Algorithms
Chatterjee, J., Neogi, S. G., & Dwivedi, R. K. (2025) · Springer tracts in human-centered computing · doi:10.1007/978-981-96-1761-6_22
Failing fast in new pharmaceutical drug development
Kraude, R., Talluri, S. K., Narayanan, S., & Hult, G. T. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28993-4.00195-5
Enhancing Emergency Response with Cloud-Based Access to Patient Medical Histories
Sharma, P., Kumar, T., & Tyagi, S. S. (2025) · International Conference on Disruptive Technologies (ICDT) · doi:10.1109/icdt63985.2025.10986368
Role of AI in Pharmaceutical Dosage Designing
Pandey, K., Pandey, S. S., Joshi, H., Bisht, S., Sharma, P. K., & Bisht, N. (2024) · International Conference on Communication, Computing and Energy Efficient Technologies (I3CEET) · doi:10.1109/i3ceet61722.2024.10994113
Transformer Generative AI Model for Enhanced Molecular Property Prediction
Kotkondawar, R. R., Sutar, S. R., Kiwelekar, A. W., & Jadhav, S. M. (2025) · Lecture notes in networks and systems · doi:10.1007/978-981-96-1185-0_7
Deep learning enhanced deciphering of brain activity maps for discovery of therapeutics for brain disorders
Zhang, X., Liu, Z., Luo, X., Cao, Y. L., Zhang, W., Li, H., Li, W., Cheng, S. H., Haggarty, S. J., Wang, X., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112868
A comprehensive review of Artificial Intelligence
Khanderao, G. J., Bakal, R. L., Kubde, J. A., Hatwar, P. R., & Karule, V. G. (2025) · GSC Advanced Research and Reviews · doi:10.30574/gscarr.2025.23.3.0155
Applications of artificial intelligence in pharmaceutical industries
Patil, G., & Dev, A. N. (2025) · International Journal of Pharmacology and Clinical Research · doi:10.33545/26647613.2025.v7.i1c.76
How do innovations generated by AI differ qualitatively from traditional innovations and what are the consequences for a firm's competitive positioning?Preprint
Mousa, S. (2025) · Research Square · doi:10.21203/rs.3.rs-6963219/v1
A Machine Learning-Based Framework for Predicting Candidate Drug Side Effects from Biological Networks
Cinaglia, P., Pingitore, G., Milano, M., & Cannataro, M. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-97554-7_7
ATTRE-Adaptive threat recognition and response engine
Koçi, A., Eissaee, B. M. A., Khaja, H. Y. A., Ameemi, A. S. A., & Shehhi, M. A. (2025) · AIP conference proceedings · doi:10.1063/5.0259371
Learning molecular machines by machine learning
Çelik, R. H., Iscil, H. A. O., Bulut, E., & Acuner, S. E. (2025) · Eurasian Journal of Science Engineering and Technology · doi:10.55696/ejset.1620495
Revolutionizing cancer care with machine learning: a comprehensive review
Leena Pavitha, P., Sannasi, G., Allan, M. P., Nithisha, D., & Suresh, A. J. (2025) · International Journal on Smart Sensing and Intelligent Systems · doi:10.2478/ijssis-2025-0037
The Potential of Generative AI in Drug Development
Gupta, D., Sudhakar, R., Mujawar, S. S., Kadam, R., Patil, V., Kumar, A., Ahire, P., & Gupta, K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-2043-4.ch005
IMPLEMENTING ARTIFICIAL INTELLIGENCE IN DRUG RESEARCH DEVELOPMENT
Obbalareddy, S., Shahi, S., & Dubey, A. (2025) · BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · doi:10.58240/1829006x-2025.21.6-361 · Cited by 4
Artificial Intelligence in Healthcare
Aknouch, A., Soussi, H., El-ouardi, Y., Belcadi, H., Aitouhanni, I., Dahbi, A., & Rachmoune, K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-1992-6.ch008
Pharmacy Innovation: A Comprehensive Overview of AI Integration
Pathan, S. D., Wagh, S. A., & M., B. S. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-28661
1Chapter 1 Drug development in virtual world: metaverse and digital twins in healthcare technology
Singh, B., & Malviya, R. (2025) · De Gruyter eBooks · doi:10.1515/9783111646893-001
Pollution risk assessment by designing predictive binary classification models of substituted benzenes centered on data mining and machine learning techniques
N’guessan, A., Dali, B., Esmel, A. E., Moussé, L. M., Ziao, N., Kre, N. R., & Megnassan, E. (2025) · Environmental Science and Pollution Research · doi:10.1007/s11356-025-36874-7 · Cited by 1
Data Science and AI for Transforming R&D
Sood, P., Kaur, G., Kumar, J., Kaur, N., Jangra, N., & Gautam, R. K. (2025) · Wiley eBooks · doi:10.1002/9781394287383.ch3
Key drivers of pharmaceutical sales in OECD countries
Višić, J. (2025) · Strategic Management · doi:10.5937/straman2500006v
Reka Digital Storytelling Integrated AI (DST-AI) Physicists: Improving Digital Literacy of Students
Muliani, D. E., Yusmanila, Y., Yuniarti, L., Manurung, K. H., Gumilar, S., Suci, N. E., & Marlina, D. (2025) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt20252209
Revolutionizing Healthcare: AI-driven Innovations in Drug Development and Personalized Medicine
Jaitawat, D. P. S., Chauhan, S. B., Jain, C., & Singh, I. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921395626250905121219 · Cited by 1
Generative AI in healthcare: Introduction, concept, applications, and challenges
Gaur, L., & Abraham, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33124-4.00013-8
EFFECT OF PILATES ON MOVEMENT PATTERNS, BALANCE AND FATIGUE LEVEL IN CHILDREN WITH SPASTIC DIPLEGIC CEREBRAL PALSY
Ashirwad, D. A. S. S., GUPTA, A., CHAUDHARY, V., & Bhati, P. (2025) · Türk fizyoterapi ve rehabilitasyon dergisi · doi:10.21653/tjpr.1377555 · Cited by 2
AI Data Applications in Drug Design, Development, and Diagnostics: A Comprehensive Approach to Modern Medicine
Singh, R., Pandey, P., Kumar, A., & Mishra, M. K. (2025) · Current Bioinformatics · doi:10.2174/0115748936370246250903052830
Introduction
Steyn, E., Oberholzer, M., Mullarkey, M. T., & Buys, P. (2025) · Springer eBooks · doi:10.1007/978-981-95-0724-5_1
From Molecule to Market: The Role of AI in Shaping Modern Pharmacoeconomics
Aziz, S., Jabal, G. A. A., Dayoob, M., Hameed, M. A., Aslam, A., & Alshehade, S. A. (2025) · Lecture notes in networks and systems · doi:10.1007/978-3-031-96631-6_23
Toward Out-of-Domain Binding Affinity Prediction
Zhao, Z., & Fang, S. (2024) · International Conference on Universal Village (UV) · doi:10.1109/uv63228.2024.11189163
AI in Regulatory Compliance for Pharmaceuticals
Mohammed, Z. A., Mohammed, M., Mohammed, S., Syed, M., & Syed, F. A. (2025) · Lecture notes in networks and systems · doi:10.1007/978-981-96-8639-1_15
Artificial intelligence in healthcare: improving diagnosis and treatment
Dewan, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26747-5.00007-0
Fundamentals of artificial intelligence in healthcare
Rane, P. B., Rane, B. R., Kothawade, S. N., & Chaure, P. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33565-5.00008-6
Forging a path forward in NARS2 ‐related neonatal diabetes: A new horizon with artificial intelligence and digital health
Sun, W., Yang, K., Wang, B., & Yang, L. (2025) · Diabetic Medicine · doi:10.1111/dme.70142
AI and Machine Learning in Modern Drug Design and Discovery
Gaikwad, S. A., & Khandare, M. V. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-29850
Pharmaceutical Automation: Leveraging Robotics and AI for Future Innovations
Mohammed, M., Mohammed, Z. A., Mohammed, S., Ehtesham, A., & Syed, M. (2025) · IEEE International Conference on Advanced Systems and Emergent Technologies (IC_ASET) · doi:10.1109/ic_aset65966.2025.11232239 · Cited by 1
Artificial intelligence in drug delivery system development
Ayyoubzadeh, S. M., Alizadeh, B., Davarikia, K., Heydari, S., & Ahmadi, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95464-8.00004-9 · Cited by 1
Artificial Intelligence in Nanomanufacturing for Optimizing Design, Fabrication, and Quality Control
Kumar, S., & Singh, H. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898812942125010010
Personalized Drug Response Prediction Using Graph Neural Networks on Patient-Specific Genomic and Transcriptomic Profiles
Jaafer, S., Jasim, A. R. O., Qasim, M. T., Abdul‐Adheem, W. R., Zaid, T. A., Asaad, A. Y. A., Hussein, R. M., & Miah, A. S. M. (2025) · International Conference on Cyber Resilience (ICCR) · doi:10.1109/iccr67387.2025.11292214
Additional file 1 of SEmHuS: a semantically embedded humanitarian space
Shamoug, A., Cranefield, S., & Dick, G. (2024) · Figshare · doi:10.6084/m9.figshare.26573314
Additional file 1 of ABT-MPNN: an atom-bond transformer-based message-passing neural network for molecular property prediction
Liu, C., Sun, Y., Davis, R. L., Cardona, S. T., & Hu, P. (2024) · Figshare · doi:10.6084/m9.figshare.26571487
A potential impact of artificial intelligence on pharmaceutical drug design and clinical trials
Aamir, M. N., Ain, Q. U., Fatima, S., Sultana, S., & Yasir, S. (2025) · Journal of Contemporary Pharmacy · doi:10.56770/jcp2025928
Introduction: The Development of Artificial Intelligence and Drug Design
Li, H. (2025) · Springer eBooks · doi:10.1007/978-981-95-2525-6_1
Novel Molecules and Materials for Drug Discovery
Singh, J., Singh, N. K., Dubey, S., Jaiswal, G., Srivastava, A., Telang, S. P., & Srivastava, S. K. (2026) · Engineering materials · doi:10.1007/978-981-95-4180-5_16
Introduction to Artificial Intelligence in Pharmaceutical Sciences
Shaikh, K., Thanki, R. M., & Shaikh, A. (2026) · Synthesis lectures on engineering, science, and technology · doi:10.1007/978-3-032-10277-5_1
Artificial Intelligence: A Current and Updated Review of Repurposed Drugs for SARS-CoV-2
Tolou–Ghamari, Z. (2026) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x382360251012171433
Ethical Considerations in AI-Driven Drug Development and Pharmaceutical Industry
Bari, Y. C., Wani, M. S., Nagare, G. D., Chogale, M. M., & Pai, R. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5258-9.ch010
Unveiling the Influence of Polyphenols on Mitogen-activated Protein Kinases in Cancer
Tendulkar, M., & Tendulkar, R. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01983-0
Pharmaceuticals in the AI Age
Neguț, I., Oliveira, C. S. F., & Vișan, A. I. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5258-9.ch001
The Use of Artificial Intelligence (AI) in Biosciences
Ukaegbu, G. N., Orji, F. A., Ori, A. P., Ofoegbu, O. V., & Okokwu, C. N. (2026) · Artificial intelligence · doi:10.5772/intechopen.1011309
Emerging Trends in Neurodegenerative Disease Treatment
Pazhamalai, V., Gokul, V., Madhumitha, L., Kumar, P. M., Meenambiga, S. S., Romauld, S. I., & M., H. N. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch003
Value Co-Creation and Artificial Intelligence
Reda, L. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-2597-2.ch007
End-to-End Digital Transformation in the Pharmaceutical Industry: A Sequential Mixed-Methods Analysis of Industry Priorities and Implementation Barriers. (Preprint)Preprint
Rodriguez-Chavez, I. R., Ibrahim, A., Ersezer, B., Radcliffe, A., Gamerman, V., Hartog, B., Iversen, L. F., & Schindler, M. (2026) · doi:10.2196/preprints.91531
Indole derivatives as antibacterials: overcoming MRSA resistance through SAR insights and AI-driven design
Yadav, S., Nema, P., Kori, S., & Kashaw, S. K. (2026) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-026-00687-0
Artificial intelligence-based technologies for advancing research and development in the pharmaceutical industry: current developments and challenges
Chavda, V. P., Vyas, A., Morakhia, K. R., Patel, S., Kulkarni, M., & Joshi, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34059-8.00011-7

Authors: Mak, K.-K., & Pichika, M. R.
Affiliations: IMU University (MY)
Corresponding author: Pichika, Mallikarjuna Rao
ORCID: Mak, Kit-Kay
Pichika, Mallikarjuna Rao
Venue: Drug Discovery Today
Publisher: Elsevier BV
Published: 2019-03
Volume: 24
Issue: 3
Pages: 773-780
ISSN: 1359-6446 (ISSN-L)
DOI: 10.1016/j.drudis.2018.11.014
OpenAlex: W2901411193
Cited by: 1,018
References: 73
Citations by year: 2026: 161 · 2025: 196 · 2024: 190 · 2023: 170 · 2022: 99 · 2021: 119 · 2020: 63 · 2019: 18
FWCI: 3.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Drug Discovery Today (publishedVersion)
PubMed (publishedVersion)
Funders: International Medical University
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
Keywords: artificial intelligence, drug development, drug discovery, attrition rates, research and development costs, pharmaceutical industry
MeSH terms: Artificial Intelligence, Drug Industry, Humans, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Artificial intelligence in drug development: present status and future prospects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks